MutationTaster evaluates disease-causing potential of sequence alterations
By J. M. Schwarz, C. Rödelsperger, M. Schuelke, D. Seelow. 2010
2,984 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Maximilian Hecht
- Burkhard Rost
- Eric Boerwinkle
- Yana Bromberg
- B. Feng
- Xiaoming Liu
- Peter N. Robinson
- Xueqiu Jian
In Molecular Biology
- Yana Bromberg
- Maximilian Hecht
- Eric Boerwinkle
- Burkhard Rost
- B. Feng
- Xiaoming Liu
- Peter N. Robinson
- Melissa A. Haendel
Citations in the corpus
- Better prediction of functional effects for sequence variants (2015, neutral): “Some tools are focused on non-coding regions [2-4]; others focus on coding regions and predict the effects of single amino acid variants (non-synonymous single-nucleotide polymorphisms, nsSNPs, or single amino acid substitutions, SAAS) on aspects such as protein structure [5], stability [6-8], bindi”
- Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data (2011, neutral): “Sequence features that are related to splicing regulation 73 are generally part of exome studies 7,8 and are also incorporated into some predictive methods 40 .”
- The SAAP pipeline and database: tools to analyze the impact and predict the pathogenicity of mutations (2013, neutral): “have a deleterious effect on phenotype [4-15].”
- A survey of tools for variant analysis of next-generation genome sequencing data (2013, methodology): “ANNOVAR uses six different scores: GERPþþ [121], LRT [122], MutationTaster [123], PolyPhen [124], PhyloP conservation [125] and SIFT [126].”
- An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge (2014, methodology): “Other tools listed by teams were PhyloP [58], likelihood ratio test scores (LRT) [59], MutationTaster [60], GERP [61], and in-house developed tools.”
- Improved exome prioritization of disease genes through cross-species phenotype comparison (2014, methodology): “The scores of MutationTaster and PolyPhen-2 are such that the score ranges from 0 (benign) to 1 (maximally pathogenic).”
- Next-generation diagnostics and disease-gene discovery with the Exomiser (2015, methodology): “…resource and from the IMPC 33 ; zebrafish data from ZFIN using the Zebrafish Anatomical Ontology 37 , Gene Ontology 42 and the PATO ontology of qualities 43 (and subsequently converted to a combined zebrafish phenotype term); pathogenicity predictions by MutationTaster 10,48 , Polyphen2 (ref.”
- LIST-S2: taxonomy based sorting of deleterious missense mutations across species (2020, methodology): “0a (17) (namely: SIFT (1), SIFT4G (18), PROVEAN (2), phyloP (3) X 3, SiPhy (5), phastCons (6) X 3, GERP++ (4), Eigen (10), CADD (9), DANN (11), W158 Nucleic Acids Research, 2020, Vol. 48, Web Server issue PolyPhen-2 (8), FATHMM-MKL (19), PrimateAI (20), MutationTast (21), MutationAssessor (22), MPC ”